LGND 114.64 (+0.61%)
US53220K5048BiotechnologyBiotechnology

Ligand Pharmaceuticals (LGND) Stock Highlights

114.64 | +0.61%
2024-12-21 03:21:59
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligands business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The companys revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

Statistics

Range Today
111 115.47
Volume Today 551.6K
Range 1 Year
67.53 129.9
Volume 1 Year 33.64M
Range 3 Year
47.79 164.84
Volume 3 Year 103.09M
Range 10 Year
47.79 278.62
Volume 10 Year 744.48M

Highlights

Market Capitalization 2.37B (mid)
Floating Shares 18.04M
Current Price 114.64
Price To Earnings 54.17
Price To Revenue 13.26
Price To Book 2.65
Earnings Per Share 2.33
Payout Ratio 0%

Performance

Latest +0.61%
1 Month +2.73%
3 Months +9.8%
6 Months +43.48%
1 Year +62.38%
3 Years -21.8%
5 Years +4.96%
10 Years +120.12%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.